ANORMED INC.
Patent Owner
Stats
- 17 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 05, 2010 most recent publication
Details
- 17 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 850 Total Citation Count
- Sep 13, 1988 Earliest Filing
- 46 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6872714 Methods to modulate conditions mediated by the CXCR4 receptorAug 13, 01Mar 29, 05[A61K, C07D, A61P]
6489472 Process for preparation of N-1 protected N ring nitrogen containing cyclic polyamines and products thereofSep 28, 01Dec 03, 02[C07D]
5756728 Process for preparing 1,1'-?1,4-phenylenebis-(methylene)!-bis-1,4,8,11-tetraazacyclotetradecaneDec 30, 96May 26, 98[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7629337 Chemokine receptor binding heterocyclic compoundsExpiredJul 27, 06Dec 08, 09[A61K, C07D, A61P]
2009/0281,308 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACYAbandonedMay 15, 09Nov 12, 09[C07D]
2007/0015,780 Method of treating cancer with azaspirane compositionsAbandonedMar 10, 04Jan 18, 07[A61K]
2006/0194,776 Compositions and methods for treating tissue ischemiaAbandonedDec 28, 05Aug 31, 06[A61K]
2006/0035,829 Chemokine combinations to mobilize progenitor/stem cellsAbandonedAug 11, 05Feb 16, 06[A61K]
2005/0250,801 Method of treating cancer with azaspirane compositionsAbandonedMar 10, 04Nov 10, 05[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.